Exploratory transcriptomic analysis suggests candidate genes associated with loss of response to ustekinumab in Crohn’s disease
BackgroundDespite the favorable safety and efficacy of ustekinumab in clinical practice for Crohn’s disease, a subset of Crohn’s disease patients still experience loss of response to this treatment. This study was thus conducted to investigate the differential gene expression underlying ustekinumab...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2026-05-01
|
| Col·lecció: | Frontiers in Genetics |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fgene.2026.1812181/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|